Cumberland Pharmaceuticals Inc. (CPIX) Share buybacks
- Total buybacks · last 12 months (USD): Value $71.44K; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $71.44K | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 71.44K USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $71.44K | (m) | (m) |
| 2026-03-31 | $78.61K | (m) | (m) |
| 2025-12-31 | $263.48K | (m) | (m) |
| 2025-09-30 | $361.86K | (m) | (m) |
| 2025-06-30 | $450.24K | (m) | (m) |
| 2025-03-31 | $577.31K | (m) | (m) |
| 2024-12-31 | $579.05K | (m) | (m) |
| 2024-09-30 | $669.64K | (m) | (m) |
| 2024-06-30 | $772.47K | (m) | (m) |
| 2024-03-31 | $801.02K | (m) | (m) |
| 2023-12-31 | $740.53K | (m) | (m) |
| 2023-09-30 | $741.22K | (m) | (m) |
| 2023-06-30 | $614.66K | (m) | (m) |
| 2023-03-31 | $660.03K | (m) | (m) |
| 2022-12-31 | $1.05M | (m) | (m) |
| 2022-09-30 | $1.22M | (m) | (m) |
| 2022-06-30 | $1.40M | (m) | (m) |
| 2022-03-31 | $1.66M | (m) | (m) |
| 2021-12-31 | $1.39M | (m) | (m) |
| 2021-09-30 | $1.33M | (m) | (m) |
| 2021-06-30 | $1.42M | (m) | (m) |
| 2021-03-31 | $1.71M | (m) | (m) |
| 2020-12-31 | $1.85M | (m) | (m) |
| 2020-09-30 | $2.45M | (m) | (m) |
| 2020-06-30 | $3.48M | (m) | (m) |
| 2020-03-31 | $3.22M | (m) | (m) |
| 2019-12-31 | $3.49M | (m) | (m) |
| 2019-09-30 | $3.09M | (m) | (m) |
| 2019-06-30 | $2.15M | (m) | (m) |
| 2019-03-31 | $2.58M | (m) | (m) |
| 2018-12-31 | $2.88M | (m) | (m) |
| 2018-09-30 | $3.21M | (m) | (m) |
| 2018-06-30 | $3.88M | (m) | (m) |
| 2018-03-31 | $4.19M | (m) | (m) |
| 2017-12-31 | $3.72M | (m) | (m) |
| 2017-09-30 | $3.54M | (m) | (m) |
| 2017-06-30 | $2.62M | (m) | (m) |
| 2017-03-31 | $2.09M | (m) | (m) |
| 2016-12-31 | $2.52M | (m) | (m) |
| 2016-09-30 | $2.55M | (m) | (m) |
| 2016-06-30 | $3.67M | (m) | (m) |
| 2016-03-31 | $4.61M | (m) | (m) |
| 2015-12-31 | $5.34M | (m) | (m) |
| 2015-09-30 | $6.25M | (m) | (m) |
| 2015-06-30 | $6.09M | (m) | (m) |
| 2015-03-31 | $5.11M | (m) | (m) |
| 2014-12-31 | $4.32M | (m) | (m) |
| 2014-09-30 | $3.62M | (m) | (m) |
| 2014-06-30 | $3.22M | (m) | (m) |
| 2014-03-31 | $3.78M | (m) | (m) |
| 2013-12-31 | $4.80M | (m) | (m) |
| 2013-09-30 | $5.18M | (m) | (m) |
| 2013-06-30 | $7.69M | (m) | (m) |
| 2013-03-31 | $7.68M | (m) | (m) |
| 2012-12-31 | $8.09M | (m) | (m) |
| 2012-09-30 | $8.19M | (m) | (m) |
| 2012-06-30 | $6.26M | (m) | (m) |
| 2012-03-31 | $5.82M | (m) | (m) |
| 2011-12-31 | $4.25M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | $4.85M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | $27.30M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |